Yuvo’s Series A deck addresses a highly specific friction point in the U.S. healthcare system: the inability of Federally Qualified Health Centers (FQHCs) to participate in lucrative value-based care (VBC) contracts due to administrative and regulatory barriers. By positioning themselves as a risk-bearing entity (an IPA/MSO hybrid), Yuvo aggregates these centers to meet patient panel requirements and manage downside risk. The deck successfully balances social mission with aggressive financial projections, moving from $0.1M in 2022 revenue to a projected $361.9M by 2026. While the deck relies…
Key takeaways
- Yuvo identifies a specific market of 1,400 FQHCs across the country that serve low-income patients (Slide 2).
- FQHCs are highly efficient, representing ~25% of Medicaid beneficiaries but only 4% of the cost (Slide 3).
- The core problem is that regulations currently prohibit FQHCs from taking on down-side risk in value-based care (Slide 4).
- Yuvo operates as a 'risk bearing entity' through a Regional IPA and National MSO structure (Slide 5).
- The founding team is 100% BIPOC and brings over 80 years of combined healthcare experience (Slide 6).
- Revenue projections show a massive leap from $9.8M in 2024 to $361.9M in 2026 as they transition to global capitation (Slide 8).
- The $20M Series A raise is allocated across Technology ($8.5M), SG&A ($7M), and Pop Health ($4.5M) (Slide 8).
- Attributed lives are expected to scale from 4k in 2022 to 180k by 2026 (Slide 8).
Executive Summary: Bridging the Gap in Medicaid Care
Yuvo’s pitch deck is a masterclass in identifying a systemic inefficiency and proposing a structural solution. The company focuses on Federally Qualified Health Centers (FQHCs), which are the backbone of the U.S. safety-net healthcare system. Despite their efficiency, these centers are locked out of modern payment models. Yuvo’s deck, which supported a $20.2M Series A in 2024, explains how they serve as the administrative and risk-bearing bridge to bring these centers into the world of value-based care (VBC).
Slide 1-3: The Macro Opportunity and the FQHC Advantage
The deck opens by framing the 'Healthcare Access Crisis.' Slide 2 identifies the three primary destinations for low-income patients: private physicians, emergency rooms, and the 1,400 FQHCs across the country. By focusing on FQHCs, Yuvo is targeting a pre-existing infrastructure that is already funded to provide care for Medicaid and uninsured individuals.
Slide 3 provides the 'Why Now' and the economic justification. It notes that FQHCs represent approximately 25% of Medicaid beneficiaries but account for only 4% of the total cost. This is a powerful efficiency metric. The slide further highlights a 24% average Medicaid savings per patient when using these centers. For an investor, this signals that the underlying assets (the health centers) are high-performing but undervalued due to systemic constraints.
Slide 4: The Regulatory Bottleneck
Slide 4, titled 'The Problem,' uses a visual of a locked gate to represent the policy barriers preventing FQHCs from performing in VBC. It lists three specific challenges: prohibitive patient panel requirements (centers are often too small to take on risk individually), laborious administrative requirements, and regulations that prohibit down-side risk. This slide is crucial because it defines Yuvo not just as a software provider, but as a regulatory and structural solution.
Slide 5: The Revenue Model and Structural Solution
This is the 'how it works' slide. Yuvo explains its role as a 'risk bearing entity.' The diagram shows Yuvo sitting between Managed Care Organizations (MCOs) and multiple FQHCs. The structure is split into two parts: a Yuvo Regional IPA (Independent Practice Association) and a Yuvo National MSO (Management Services Organization). The MSO provides the 'National' infrastructure—data analytics, risk adjustment, and practice transformation—while the IPA handles the local risk contracts. This allows Yuvo to aggregate small centers into a single large panel that meets the requirements for value-based contracts.
Slide 6: The Team as a Competitive Moat
In highly regulated industries like healthcare, the team is often the most important slide. Yuvo highlights a '100% BIPOC Founding Team' with over 80 years of combined experience. The slide lists specific, high-tier prior experience for the four founders, including Healthify, Zocdoc, Booz & Co, Emblem Health, and the American University Law Faculty. This mix of legal, operational, and strategic healthcare experience is intended to de-risk the complex execution required to manage Medicaid risk contracts.
Slide 7: Social Proof and CEO Validation
Slide 7 moves away from data to provide qualitative validation through three CEO testimonials. Dr. Miriam Vega (Joseph P. Addabbo Family Health Center), Dr. Rita Bilello (Metro Community Health Centers), and Dr. Jim Powell (Long Island Select Healthcare) all speak to the isolation and administrative burden of running these centers. The quotes emphasize that Yuvo acts as a 'sounding board' and helps 'maximize reimbursements' that the states are currently failing to provide efficiently.
Slide 8: The Financial Path to $361M
The final slide in this set is the 'Ask' and the 'Projections.' Yuvo is seeking $20M to fuel their transition to 'global capitation'—a model where they receive a set fee per patient and keep the savings generated by better care. The revenue projections are extremely aggressive:
2022: $0.1M (4k attributed lives) · 2023: $1.3M (26k attributed lives) · 2024: $9.8M (52k attributed lives) · 2025: $84.4M (103k attributed lives) · 2026: $361.9M (180k attributed lives)
The slide also breaks down the use of funds: $8.5M for Technology, $7M for SG&A, and $4.5M for Pop Health. This clear allocation shows that the Series A is primarily a scaling round intended to build the technological infrastructure to support a massive increase in patient volume.
What Yuvo Does Well
Specific Problem Identification: Many healthcare decks try to 'fix healthcare' broadly. Yuvo identifies a specific segment (FQHCs) and a specific barrier (VBC participation) and offers a specific structural solution (IPA/MSO). This specificity makes the business model much more believable.
Economic Alignment: The deck successfully argues that FQHCs are already saving the system money (Slide 3), and Yuvo is simply the mechanism to capture that existing value. It doesn't require a change in patient behavior, only a change in how the money flows between payers and providers.
Team-Market Fit: By highlighting their BIPOC status and deep healthcare backgrounds, the founders align themselves culturally and professionally with the community health centers they serve. This is a subtle but effective way to demonstrate they have the 'trust' required to sign up these partners.
What is Missing from the Deck
Unit Economics: While the total revenue projections are clear, the deck (in these 8 slides) does not detail the margin profile of a single 'attributed life.' We see the top-line growth, but not the cost of care management or the percentage of savings Yuvo retains vs. what is passed back to the FQHC.
Competitive Landscape: There is no mention of other MSOs or technology platforms that might be targeting the FQHC market. Investors would likely want to know how Yuvo protects its territory once an FQHC is onboarded.
Regulatory Risk Disclosure: The entire model relies on current Medicaid and FQHC regulations. A 'Risk' slide explaining how they handle potential changes in federal or state funding for community health centers would have added a layer of sophistication to the deck.
Founder Takeaways: How to Build a Similar Deck
Use the 'Structural Gap' Narrative: If your startup solves a problem created by regulation or 'the way things have always been done,' use a slide like Slide 4 to visualize that barrier. A 'locked gate' or 'bottleneck' image helps investors immediately grasp why a solution hasn't existed until now.
Aggregate for Scale: If your target customers are small and fragmented, show how you aggregate them to create a 'whale' that can negotiate with larger entities. Yuvo’s Slide 5 is a perfect example of how to visualize an intermediary business model.
Tie Projections to a Physical Metric: Yuvo doesn't just show revenue; they show 'Attributed Lives' (Slide 8). For any B2B2C or managed care business, tying your dollar amounts to the number of people served makes the projections feel grounded in reality rather than just spreadsheet magic.
Focus on Efficiency First: Before asking for money to grow, prove that the sector you are entering is already efficient. Slide 3’s note that FQHCs handle 25% of patients for 4% of the cost is the 'hook' that makes the rest of the investment thesis work. It proves there is 'alpha' to be captured.
Frequently asked questions
- What is Yuvo's primary value proposition for health centers?
- Yuvo helps Federally Qualified Health Centers (FQHCs) overcome three main barriers to value-based care: prohibitive patient panel requirements, costly administrative burdens, and regulations that prevent these centers from taking on down-side risk. By acting as a risk-bearing intermediary, Yuvo allows these centers to access higher reimbursement rates and sustainable revenue streams that they could not access independently.
- How does Yuvo actually make money?
- According to Slide 5, Yuvo utilizes a dual structure consisting of a Regional Independent Practice Association (IPA) and a National Management Services Organization (MSO). They act as the risk-bearing entity between Managed Care Organizations (MCOs) and FQHCs. This allows them to capture value from global capitation contracts, providing services like data analytics, risk adjustment coding, and patient engagement.
- Why is the founding team's background emphasized?
- Healthcare regulation, especially regarding Medicaid and FQHCs, is incredibly complex. Yuvo highlights their 100% BIPOC founding team's 80+ years of experience at organizations like Zocdoc, Emblem Health, and the Mercy Health System to prove they have the specific domain expertise required to navigate these legal and operational hurdles (Slide 6).
- What are the projected growth metrics for the Series A round?
- The deck projects an aggressive hockey-stick growth curve. Revenue is expected to grow from $9.8M in 2024 to $84.4M in 2025, reaching $361.9M by 2026. This growth is tied to the scaling of 'attributed lives'—the number of patients covered under their managed care contracts—which they expect to grow from 52,000 to 180,000 in that same period (Slide 8).
- How will the $20 million investment be spent?
- As detailed on Slide 8, the largest portion of the $20M raise is dedicated to Technology ($8.5M), followed by Selling, General, and Administrative expenses ($7M), and Population Health initiatives ($4.5M). The goal of this spending is to build the 'table stakes technology' and population health scalability needed to unlock sustainable global capitation revenue.
